# Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)

Study · id `cardio:ct-nct01472926` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01472926](<https://clinicaltrials.gov/study/NCT01472926>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01472926

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

## Technical summary

Registry record NCT01472926. Randomized; single masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-12-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT01472926, source copy `cardio:ctgov-nct01472926-2018-08-03`, retrieved 2026-10-26)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01472926, source copy `cardio:ctgov-nct01472926-2018-08-03`, retrieved 2026-10-26)
- Primary completion: 2013-12-10 (actual) (ClinicalTrials.gov record NCT01472926, source copy `cardio:ctgov-nct01472926-2018-08-03`, retrieved 2026-10-26)
- Completion: 2013-12-10 (actual) (ClinicalTrials.gov record NCT01472926, source copy `cardio:ctgov-nct01472926-2018-08-03`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01472926, source copy `cardio:ctgov-nct01472926-2018-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01472926-2018-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)
- Acronym: ATTEST
- Condition: Stroke
- Intervention (Drug): Tenecteplase
- Intervention (Drug): alteplase
- Lead sponsor: NHS Greater Glasgow and Clyde
- Lead sponsor class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry lists this organization as the lead sponsor: NHS Greater Glasgow and Clyde (`cardio:org-nhs-greater-glasgow-and-clyde`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study (`cardio:pubmed-25726502`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke (`cardio:pubmed-26514192`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials (`cardio:pubmed-27965285`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0c7d9ef445319fbd7dc95ca5f77746eb10be6a1ab575b7fa598a9ade1f970323
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
